Protein R&D is slow and resource-intensive because sequence design, experimental validation and process learning often operate as disconnected workflows.
R&D Focus
AI protein design, enzyme mining, directed evolution and automated laboratories.
Innovative Solution
Combines the MatwingsVenus protein language model, conversational design agent, large protein-sequence datasets and robotic experimental systems in an end-to-end platform.
Solution Effectiveness
The company reports a dataset containing tens of billions of protein sequences and billions of annotations; no customer-validated time or cost reduction was found.
Investment Funding
Last Funding Stage
Series A
Total Funding Amount
13.83M
Last Funding Amount
13.83M
Last Funding Date
15-11-2024
Startup Stage
Early Stage
Lead Investors
Qiming Venture Partners, 3E Bioventures, Yonghua Capital, Jingtao Venture Capital
Revenue
$1M to $10M
About
Matwings is a biotechnology industry that moves evolution methods to design functionally optimized proteins by leveraging a proprietary.
Products
Product
MatwingsVenus Agent, MatwingsVenus PLM and MatwingsVenus Auto.
Star Product
MatwingsVenus platform – integrates AI protein design with automated experimental validation.
Demo Product or Complete Product?
Commercial B2B protein-R&D software and automated-laboratory platform.
Something missing or incorrect on this page? Help us enrich this information
